Study | PEDro criteria | Total |
|---|
1 | 2 | 3 | 4 | 5 | 6 | 7 | 8 | 9 | 10 | 11 |
|---|
Babazadeh [15] | Y | Y | Y | Y | Y | N | Y | Y | Y | Y | Y | 10 |
Pang [11] | Y | Y | Y | Y | Y | N | Y | Y | Y | Y | Y | 10 |
Lee DH [24] | Y | Y | Y | Y | Y | N | Y | N | Y | Y | Y | 9 |
Baier [9] | Y | Y | N | Y | Y | N | N | Y | Y | N | Y | 7 |
Lee HJ [13] | Y | Y | N | Y | Y | N | N | Y | Y | Y | N | 7 |
Singh [12] | Y | Y | N | N | Y | N | Y | Y | N | Y | N | 6 |
Nikolaides [14] | Y | N | N | Y | N | N | N | N | N | Y | Y | 4 |
Luyckx [8] | Y | N | N | Y | N | N | N | N | N | Y | Y | 4 |
Sabbioni [20] | N | N | N | Y | N | N | N | N | N | Y | Y | 3 |
Tigani [19] | Y | N | N | N | N | N | N | N | N | Y | Y | 3 |
Dennis [23] | Y | N | N | N | N | N | N | N | N | Y | N | 2 |
- Y Yes, N No
- 1. Eligibility criteria
- 2. Random allocation
- 3. Concealed allocation
- 4. Baseline comparability
- 5. Blind subject
- 6. Blind clinician
- 7. Blind assessor
- 8. Adequate follow-up
- 9. Intention-to-treat analysis
- 10. Between-group analysis
- 11. Point estimates and variability
